Medilink Therapeutics is based in Suzhou, China. It has raised $120M in total funding. Latest round: Series B.
Medilink Therapeutics is based in Suzhou, China. Medilink Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Medilink Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include LYFE Capital, Qiming Venture Partners, Legend Capital, Loyal Valley Capital, Highlight Capital, Apricot Capital. 6 distinct backers are named across the disclosed rounds.
Medilink Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026